Guggenheim flags this biotech stocks as one of its top picks

June 18, 2026 11:00 PM

Investing.com -- Celldex Therapeutics' experimental bispecific antibody CDX-622 demonstrated deep and sustained suppression of serum tryptase, a key marker of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found